Chemistry:Lepetegravir

From HandWiki

Lepetegravir is an investigational new drug that is being developed by Gilead Sciences for the treatment of HIV-1 infection. It is a HIV integrase inhibitor.[1][2]

References

  1. ↑ "Lepetegravir". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800072437. 
  2. ↑ "Future options for long-acting HIV treatment and prevention". Current Opinion in HIV and AIDS 20 (1): 39–47. January 2025. doi:10.1097/COH.0000000000000901. PMID 39560965. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Lepetegravir&oldid=4583456"